LONDON -- Treating herpes simplex with valacylovir (Valtrex) reduces the levels of HIV in women who are infected with both viruses, according to researchers here.
LONDON, Feb. 21 -- Treating herpes simplex with valacylovir (Valtrex) reduces the level of HIV in women who are infected with both viruses, according to researchers here.
The finding -- from a randomized, double-blind, placebo-controlled trial in Africa -- could help improve the control of HIV transmission, according to Nicolas Nagot, M.D., of the London School of Hygiene and Tropical Medicine.
Valacyclovir significantly reduces (P
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.